Efficacy and safety from a phase 2B trial of SM04690, a novel, intra-articular, WNT pathway inhibitor for the treatment of osteoarthritis of the knee

Saved in:
Bibliographic Details
Published inOsteoarthritis and cartilage Vol. 27; p. S503
Main Authors Yazici, Y., McAlindon, T.E., Gibofsky, A., Lane, N.E., Latterman, C., Skrepnik, N., Swearingen, C.J., DiFrancesco, A., Tambiah, J.R., Hochberg, M.C.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.04.2019
Online AccessGet full text

Cover

More Information
ISSN:1063-4584
1522-9653
DOI:10.1016/j.joca.2019.02.566